NCI NCI
Company Profile ↓Company Overview
NCI (NCI) is a publicly traded company listed on with a market capitalization of $5.97M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 0.7.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $137.25M (-41.8% YoY); net profit $331.68K.
- Trailing 12 Months Year-on-year growth — revenue -41.8%, earnings -95.9%.
- 5-Year Trend Long-term compounding — revenue CAGR -26.6%, profit CAGR -70.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -26.63% |
| 1 Year: | -41.76% |
Compounded Profit Growth
| 5 Years: | -70.09% |
| 1 Year: | -95.89% |
Stock Price Performance
| 1 Year: | -18.33% |
| 6 Months: | +17.32% |
| 3 Months: | +37.38% |
| 1 Month: | +2.22% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)49.47 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
CONS
- Revenue declined at -26.6% CAGR over 5 years.
- Earnings shrank at -70.1% CAGR over 5 years.
- Trading 87.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 347.45M | 174.20M | 235.67M | 137.25M |
| Cost of Revenue | - | 305.62M | 139.15M | 186.22M | 86.56M |
| Gross Profit | - | 41.83M | 35.05M | 49.44M | 50.69M |
| Operating Expenses | - | 22.90M | 26.00M | 37.87M | 48.88M |
| Operating Income | - | 18.94M | 9.05M | 11.57M | 1.80M |
| EBITDA | - | 24.86M | 11.64M | 15.08M | 7.36M |
| Interest Expense | - | 6.13M | 5.76M | 3.76M | 1.35M |
| Pretax Income | - | 15.38M | 5.74M | 9.15M | 1.78M |
| Tax Provision | - | 2.98M | 1.33M | 1.09M | 1.45M |
| Net Income | - | 12.40M | 4.41M | 8.06M | 331.68K |
| Diluted EPS | 10.73 | 19.35 | 8.69 | 16.48 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 41.87M | 90.62M | 135.65M | 115.63M |
| Current Assets | - | 40.89M | 63.74M | 72.34M | 52.57M |
| Cash & Equivalents | - | 8.59M | 5.85M | 9.17M | 2.33M |
| Inventory | - | 1.30M | 5.32M | 3.62M | 12.11M |
| Receivables | - | 10.34M | 32.34M | 34.17M | 7.29M |
| Total Liabilities | - | 102.55M | 93.00M | 78.82M | 59.03M |
| Current Liabilities | - | 102.17M | 69.83M | 39.30M | 20.15M |
| Long Term Debt | 525.62K | 375.06K | - | - | - |
| Total Debt | - | 84.99M | 54.64M | 69.60M | 46.44M |
| Total Equity | - | -60.68M | -2.39M | 56.83M | 56.60M |
| Shares Outstanding | - | 508.00K | 508.00K | 508.00K | 508.00K |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -42.76M | -49.01M | 428.24K | 21.37M |
| Investing Cash Flow | - | -73.53K | -1.28M | -19.17M | -4.01M |
| Financing Cash Flow | - | 50.00M | 47.55M | 21.89M | -22.83M |
| Capital Expenditure | - | -73.53K | -1.28M | -19.17M | -4.01M |
| Free Cash Flow | - | -42.83M | -50.29M | -18.74M | 17.37M |
| Net Change in Cash | - | 7.16M | -2.74M | 3.15M | -5.46M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 12.0% | 20.1% | 21.0% | 36.9% |
| Operating Margin % | - | 5.4% | 5.2% | 4.9% | 1.3% |
| Net Margin % | - | 3.6% | 2.5% | 3.4% | 0.2% |
| ROE % | - | -20.4% | -185.0% | 14.2% | 0.6% |
| ROCE % | - | -31.4% | 43.5% | 12.0% | 1.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NCI
Is Neo-Concept International Group Holdings Limited's (NASDAQ:NCI) Recent Stock Performance Tethered To Its Strong Fundamentals? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxPRHVqYTNSTldsaXUwSWVyYVQ4c2xqR2FCLW9ZRGhwWTlJblJTME5DMUc0RFdRUmI4ZG5tYzZCTzQ1MDdNV0w5czBsS1JNVUN0MzNlTHktZ3RQcGFCcTBmM0Q2eGx0dmthdzJGcUxEaWQ4dWRHWTE4UkJ4SC1Nd1JVMjJmbFVhblFyLUVEUT…
Neo-Concept International Group Holdings Ltd SEC Filing (Jul 31, 2026) - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNM3RlOWo5eWFyQ203UDVLNUd3a21wU1FOY29DYkxsTks3dWpITUp0aml6LU9MaHRwMzBwcmFDY0xSTFhlZFA0MFFfWHBrM1FqX3VIemh4MHNXTWVDQ096MWdmOGRUWFNEV3B0SlFrTjNTTjRzNnZiLUZUUUxZQXEzNEd6a0ZZMlVqd2dycW…
NCI Stock Rises Amid Strategic Expansion Efforts - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNTUxvbkd1QzZ6aDNXT1U3Sy1zWldlWlA2ZWxJSU9xTVQ5c2l6WTlrUkZBLUxOSVpieTBvdHpjSDI3clM0R3FfUHJ0WkhlbzlCbF8xemRrdEtfX0ZVbXM3TlA1Q2wwU09BakF4ckJ0YU41azhoaTA3MDl0UVVSelMxeDBHSjBlOHdLYVJURj…
Wednesday's session: gap up and gap down stocks - ChartMill
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQSWRaZlZNVGpTbVlONkNvaDliR0EtTmtENTVMZVp6Z1lUVnptWVM1OW1lRFZWbTA1MjMzYktXcDVOaFI4dlVNLUtnLTdnZFIxOVdhazl2TDR0SEJveVZoWFJ2MVBweGEyajJFNlppbzR2LUo1VUQ1c0JtUjVzckVCZE12VWdYU3k4d2tFNk…
Little Excitement Around Neo-Concept International Group Holdings Limited's (NASDAQ:NCI) Earnings As Shares Take 39% Pounding - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi-wFBVV95cUxPZW5Fck5Wa2pyY3FpeWJ0NHZqdHFfZW83MjZXSmUwWkJTa3h5TFlLWmItMjREVEh1bHZDcjZUZVgzNzk3NkFiQ1dGWG5sUXV1SG9ubXZ4ZTNUVWE4OU5vUDVsMk1nTHY0RDNfRWVlLUJqQlhqZndnWTBpUmY0UHFDS0RHeFdBb0NrcDhjb0…
NeoConcept stock tumbles after pricing public offering - Investing.com
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPVXB6SjIwU3JBY3kxMVR2cUJkcE5ORERCM2hXdVRlVFdXbGk2emtQWjZ4Z01tTjlTRzRlcElOYzZGLXQ1YkVFTmN0MFVUZTFMdy0xYy1rSUYtQVVMbG43QVBuSF9aZ2NFYVgtSldrUUFjcF81QndicXRMOXFhQTdEVFVOZlc5VkxWUGdXUS…
NCI — Frequently Asked Questions
What is the current share price of NCI?
As of 2026-08-05 17:25 PDT, NCI trades at $11.76 on NASDAQ/NYSE. Its 52-week range is $3.95 to $96.00.
What is the market capitalisation of NCI?
NCI has a market capitalisation of $5.97M on NASDAQ/NYSE.
What is the P/E ratio of NCI?
NCI trades at a trailing price-to-earnings (P/E) ratio of 0.71. Its price-to-book (P/B) ratio is 0.11.
What is the return on equity (ROE) of NCI?
NCI has a return on equity (ROE) of 0.59%. Its return on capital employed (ROCE) is 1.89%.
Is NCI a good stock to buy?
This page provides a data-driven analysis of NCI, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.